Bioasia 2025 Concludes On A High Note, Cementing Telangana’s Global Leadership In Life Sciences

Out of 84 startups shortlisted for Bio Asia 2025 top 5 most innovative Startups were recognized for their groundbreaking innovation in the life sciences landscape. The winners were selected by an esteemed panel of industry experts.

The startups receiving the award were:

1.SemGenome

2.Genica Bioscience

3.ProEnz Biosciences

4.Boltzmann Labs

5.Utopia Therapeutics

Addressing the audience virtually Mr. Piyush Goel, Hon’ble Minister for Industry and Supply, Government of Indiasaid, “Telangana has established itself as a leading healthcare hub, home to India's largest pharma clusters and biotech research centres. This year's theme Catalysts of Change, Expanding Global Healthcare Frontiers perfectly captures India's evolving role. From pandemic to digital solutions, India offers unmatched talent, cost advantages and a thriving innovation ecosystem. As we accelerate in global economic race under Prime Minister Modi, the people of Telangana are also benefiting from transformational reforms like Kakatiya Mega -Textile park in Warangal, Industrial node in Zaheerabad and an All India Institute of Medical Sciences at Bibi Nagar whose foundation stone was recently laid. I urge global investors and industry leaders to seize the immense opportunities that India presents. Let us work hand in hand to drive innovation, expand healthcare frontiers and make cutting edge medical solutions accessible to all.”

According to Mr. G. Kishan Reddy, Hon’ble Minister for Coals and Mines, Government of India, “This event shows India's strong leadership in life sciences, pharmaceuticals and healthcare innovation. It is indeed a matter of pride that Hyderabad is truly the bulk drug capital and the vaccine capital of India. With a strong background in both life sciences and technology, Hyderabad is ready to take on a bigger role on the global stage. Hyderabad is a home to over 800 pharma biotech and Meditech companies creating a strong ecosystem for growth and innovation. I see many brilliant minds here who have the potential to transform the future of health care.”

According to Mr. D. Sridhar Babu, Hon’ble minister of Industries and Commerce, Government of Telangana, “BioAsia 2025 has been a phenomenal success and we witnessed a great response from all participants . This year's edition has surpassed all expectations and we have crossed last year's attendance number, making it the largest edition ever. This edition facilitated more than 200 high-impactB2B meetings, unlocking new collaborations and investment opportunities.We would like to make a special mention the C4IR Telangana Centre, which has successfully completed its first year. It has played a pivotal role in fostering digital health, building a skilled workforce, and driving healthcare solutions. In Telangana we are committed to skilling and workforce development and will ensure that our talent pool is future-ready to lead the next wave of biotech and HealthTech innovation. We are proud to announce the successful completion of our synthetic organic chemistry batch, under the skilling initiative by C4IR Telangana. Some socio-economic statistics of our program -82% of the students are female with 60% of them have completed their schooling in tier 2 and 3 cities or villages.This program provides them with a valuable opportunity to advance their careers and improve their socio-economic status. This was made possible with the support of 4 industry partners - Syngene, Aragen, Sai Lifesciences and Aurigene. BioAsia has truly maintained its position at a global stage for healthcare and life sciences, and Telangana stands at the forefront of this revolution. As we conclude this landmark edition, let us carry forward the spirit of innovation, collaboration, and ambition, knowing that together we can overcome everything.”

The event featured an impressive lineup of about 100 distinguished speakers, including top executives, renowned scientists, and government dignitaries, who shared their expertise on emerging trends and transformative breakthroughs in life sciences. Delegates from across the world, representing leading pharmaceutical and biotech companies, research institutions, and regulatory agencies, contributed to the dynamic discussions aimed at shaping the future of the sector.

As the curtains close on yet another impactful edition, BioAsia continues to be the bridge between innovation and enterprise, fostering the next wave of transformative solutions that will redefine global healthcare. With growing international engagement and an expanding scope, anticipation for BioAsia 2026 is already building, promising to be even more influential in driving the future of life sciences.

Details of the award winning startups at Bio Asia 2025:

1. SemGenome

At SemGenome by Semantic Web Tech, we are revolutionizing knowledge management in Life Sciences, Genomics, and Public Health. Our flagship platform enables labs, hospitals, clinicians and pharma companies with precision variant analysis for clinical insights. BioAsia has been a highly impactful event with gathering from across globe reinforcing Telengana State's deep focus and support to this sector. We are deeply grateful to the Bio Asia organisers for giving us an opportunity to present our business.

2. Genica Bioscience

Genica Biosciences based in Hyderabad, Telangana, India, is a pioneering biotechnology company dedicated to advancing research and development in molecular and cellular technologies. Specializing in innovative healthcare solutions, we focus on developing research tools, diagnostics, and therapeutic proteins. With a commitment to excellence, we offer consulting services to support biotech ventures. Our expertise encompasses the development of diagnostic assays, contributing to the evolution of biotechnology and enhancing healthcare worldwide. Genica Biosciences strives to be at the forefront of scientific innovation, driving progress and improving lives through cutting-edge biotechnological advancements.

3. ProEnz Biosciences

ProEnz Biosciences is a molecular diagnostics startup company based out of Hyderabad working in cancer diagnostics kits for PCR technique on Breast, Colon and lung cancers. The company vision is to develop the accurate and faster diagnostic kits for diagnosis of cancers

4. Boltzmann Labs

Boltzmann Labs is revolutionizing AI-driven drug discovery with advanced platforms for small molecules, protein engineering, and clinical trial optimization. Our unified platform integrates AI agents, autonomous workflows, and self-driving labs to accelerate scientific research. By combining machine learning with automation, we streamline R&D and enable breakthrough innovations. Our mission is to make scientific discovery faster, more efficient, and accessible to researchers worldwide. Boltzmann Labs is driving global biotech innovation from India, shaping the future of AI-powered life sciences.

5. Utopia Therapeutics

Utopia Therapeutics is an emerging start up dedicated to discovering the most innovative products for global unmet needs with focus on the needs of Indian population. India is a growing capital of metabolic diseases such as fatty liver and obesity. Utopias vaccine is designed to provide help to several million patients with a first of it’s kind approach to disease management.